TGFBR2 and breast cancer: In breast cancer (BC) models, the cytoplasmic isoform USP19 stabilizes both the TβRI and TβRII to enhance TGF-β-induced EMT and cell migration, whereas the endoplasmic reticulum-localized isoform USP19 inhibits EMT by reducing TβRI surface expression 173.